Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had established a management consensus guideline in 2016. The current recommendations focus on updating critical issues regarding...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664620305313 |
id |
doaj-602033b060fa4a748f841fd37bd8fefc |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu-Yun Shao Shen-Yung Wang Shi-Ming Lin Kuan-Yang Chen Jeng-Hwei Tseng Ming-Chih Ho Rheun-Chuan Lee Po-Chin Liang Li-Ying Liao Kai-Wen Huang Jui-Ting Hu Ja-Der Liang Shen-Yung Wang Kwong-Ming Kee Chih-Lin Lin Shi-Ming Lin Chung-Kwe Wang Sheng-Nan Lu Jing-Houng Wang Wei-Chen Lee Chien-Hung Chen Chun-Jen Liu Yi-Hsiang Huang Chia-Chi Wang Tsang-En Wang Po-Heng Chuang Chia-Yen Dai Chiun Hsu Yu-Yun Shao San-Chi Chen Chia-Hsun Hsieh |
spellingShingle |
Yu-Yun Shao Shen-Yung Wang Shi-Ming Lin Kuan-Yang Chen Jeng-Hwei Tseng Ming-Chih Ho Rheun-Chuan Lee Po-Chin Liang Li-Ying Liao Kai-Wen Huang Jui-Ting Hu Ja-Der Liang Shen-Yung Wang Kwong-Ming Kee Chih-Lin Lin Shi-Ming Lin Chung-Kwe Wang Sheng-Nan Lu Jing-Houng Wang Wei-Chen Lee Chien-Hung Chen Chun-Jen Liu Yi-Hsiang Huang Chia-Chi Wang Tsang-En Wang Po-Heng Chuang Chia-Yen Dai Chiun Hsu Yu-Yun Shao San-Chi Chen Chia-Hsun Hsieh Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Journal of the Formosan Medical Association Hepatocellular carcinoma Guideline Surveillance Diagnosis Systemic treatment |
author_facet |
Yu-Yun Shao Shen-Yung Wang Shi-Ming Lin Kuan-Yang Chen Jeng-Hwei Tseng Ming-Chih Ho Rheun-Chuan Lee Po-Chin Liang Li-Ying Liao Kai-Wen Huang Jui-Ting Hu Ja-Der Liang Shen-Yung Wang Kwong-Ming Kee Chih-Lin Lin Shi-Ming Lin Chung-Kwe Wang Sheng-Nan Lu Jing-Houng Wang Wei-Chen Lee Chien-Hung Chen Chun-Jen Liu Yi-Hsiang Huang Chia-Chi Wang Tsang-En Wang Po-Heng Chuang Chia-Yen Dai Chiun Hsu Yu-Yun Shao San-Chi Chen Chia-Hsun Hsieh |
author_sort |
Yu-Yun Shao |
title |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
title_short |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
title_full |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
title_fullStr |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
title_full_unstemmed |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan |
title_sort |
management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the taiwan liver cancer association and the gastroenterological society of taiwan |
publisher |
Elsevier |
series |
Journal of the Formosan Medical Association |
issn |
0929-6646 |
publishDate |
2021-04-01 |
description |
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had established a management consensus guideline in 2016. The current recommendations focus on updating critical issues regarding the management of HCC, including surveillance, diagnosis, and systemic treatment. For surveillance, the updated guideline suggests the role of dynamic computed tomography or magnetic resonance imaging and contrast-enhanced ultrasound (CEUS) in selected patients. For diagnosis, this update incorporates CEUS and recognizes the role of gadoxetic acid–enhanced magnetic resonance imaging. For systemic therapy, the updated guideline summarizes the multiple choices of targeted therapy, immune checkpoint inhibitors, and the combination of both. Through this update of the management consensus guideline, patients with HCC can benefit from receiving optimal diagnostic and therapeutic modalities. |
topic |
Hepatocellular carcinoma Guideline Surveillance Diagnosis Systemic treatment |
url |
http://www.sciencedirect.com/science/article/pii/S0929664620305313 |
work_keys_str_mv |
AT yuyunshao managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT shenyungwang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT shiminglin managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT kuanyangchen managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT jenghweitseng managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT mingchihho managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT rheunchuanlee managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT pochinliang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT liyingliao managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT kaiwenhuang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT juitinghu managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT jaderliang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT shenyungwang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT kwongmingkee managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chihlinlin managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT shiminglin managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chungkwewang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT shengnanlu managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT jinghoungwang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT weichenlee managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chienhungchen managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chunjenliu managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT yihsianghuang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chiachiwang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT tsangenwang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT pohengchuang managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chiayendai managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chiunhsu managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT yuyunshao managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT sanchichen managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan AT chiahsunhsieh managementconsensusguidelineforhepatocellularcarcinoma2020updateonsurveillancediagnosisandsystemictreatmentbythetaiwanlivercancerassociationandthegastroenterologicalsocietyoftaiwan |
_version_ |
1724228229992022016 |
spelling |
doaj-602033b060fa4a748f841fd37bd8fefc2021-03-09T04:11:54ZengElsevierJournal of the Formosan Medical Association0929-66462021-04-01120410511060Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of TaiwanYu-Yun Shao0Shen-Yung Wang1Shi-Ming Lin2Kuan-Yang Chen3Jeng-Hwei Tseng4Ming-Chih Ho5Rheun-Chuan Lee6Po-Chin Liang7Li-Ying Liao8Kai-Wen Huang9Jui-Ting Hu10Ja-Der Liang11Shen-Yung Wang12Kwong-Ming Kee13Chih-Lin Lin14Shi-Ming Lin15Chung-Kwe Wang16Sheng-Nan Lu17Jing-Houng Wang18Wei-Chen Lee19Chien-Hung Chen20Chun-Jen Liu21Yi-Hsiang Huang22Chia-Chi Wang23Tsang-En Wang24Po-Heng Chuang25Chia-Yen Dai26Chiun Hsu27Yu-Yun Shao28San-Chi Chen29Chia-Hsun Hsieh30Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, TaiwanDivision of Gastroenterology and Hepatology, Department of Medicine, MacKay Memorial Hospital, Taipei, TaiwanGraduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Division of Gastroenterology and Hepatology, Department of Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Corresponding author. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou branch, 199, Tung Hwa North Road, Taipei, 105, Taiwan. Fax: +886 3 3282824.Renai Branch, Taipei City Hospital, Taipei, TaiwanChang Gung Memorial Hospital, Linkuo, TaiwanNational Taiwan University Hospital, Taipei, TaiwanTaipei Veterans General Hospital, Taipei, TaiwanNational Taiwan University Hospital, Taipei, TaiwanRenai Branch, Taipei City Hospital, Taipei, TaiwanNational Taiwan University Hospital, Taipei, TaiwanCathay General Hospital, Taipei, TaiwanNational Taiwan University Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanKaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanRenai Branch, Taipei City Hospital, Taipei, TaiwanChang Gung Memorial Hospital, Linkuo, TaiwanKang Ning Hospital, Taipei, TaiwanKaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanKaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanChang Gung Memorial Hospital, Linkuo, TaiwanNational Taiwan University Hospital Yunlin Branch, Yunlin, TaiwanNational Taiwan University Hospital, Taipei, TaiwanTaipei Veterans General Hospital, Taipei, TaiwanTaipei Tzu Chi Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanChina Medical University Hospital, Taichung, TaiwanKaohsiung Medical University Hospital, Kaohsiung, TaiwanNational Taiwan University Hospital, Taipei, TaiwanNational Taiwan University Hospital, Taipei, TaiwanTaipei Veterans General Hospital, Taipei, TaiwanChang Gung Memorial Hospital, Linkuo, TaiwanHepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had established a management consensus guideline in 2016. The current recommendations focus on updating critical issues regarding the management of HCC, including surveillance, diagnosis, and systemic treatment. For surveillance, the updated guideline suggests the role of dynamic computed tomography or magnetic resonance imaging and contrast-enhanced ultrasound (CEUS) in selected patients. For diagnosis, this update incorporates CEUS and recognizes the role of gadoxetic acid–enhanced magnetic resonance imaging. For systemic therapy, the updated guideline summarizes the multiple choices of targeted therapy, immune checkpoint inhibitors, and the combination of both. Through this update of the management consensus guideline, patients with HCC can benefit from receiving optimal diagnostic and therapeutic modalities.http://www.sciencedirect.com/science/article/pii/S0929664620305313Hepatocellular carcinomaGuidelineSurveillanceDiagnosisSystemic treatment |